ArticleNPJ breast cancer2023

Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients.

Linda Vidarsdottir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.